Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2066) 2066
Publication (238) 238
Newsletter (84) 84
Book / eBook (55) 55
Book Chapter (55) 55
Book Review (45) 45
Newspaper Article (37) 37
Conference Proceeding (7) 7
Dissertation (2) 2
Magazine Article (2) 2
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1515) 1515
index medicus (1100) 1100
female (895) 895
lymphomas (884) 884
male (872) 872
middle aged (811) 811
oncology (737) 737
aged (731) 731
adult (684) 684
lymphoma (621) 621
hematology (560) 560
cancer (518) 518
b-cell lymphoma (442) 442
epidemiology (431) 431
aged, 80 and over (413) 413
non-hodgkin's lymphomas (406) 406
non-hodgkins-lymphoma (371) 371
risk factors (358) 358
prognosis (325) 325
research (289) 289
pathology (286) 286
chemotherapy (276) 276
adolescent (267) 267
hemic and lymphatic diseases (257) 257
diagnosis (252) 252
retrospective studies (252) 252
incidence (241) 241
medicine & public health (240) 240
young adult (237) 237
care and treatment (230) 230
health aspects (223) 223
non-hodgkin lymphoma (221) 221
analysis (211) 211
lymphoma, non-hodgkin - epidemiology (198) 198
risk (193) 193
rituximab (189) 189
classification (183) 183
treatment outcome (182) 182
follicular lymphoma (177) 177
leukemia (176) 176
immune system diseases (175) 175
disease (167) 167
case-control studies (165) 165
prevalence (163) 163
neoplasm staging (157) 157
lymphoma, b-cell, marginal zone - epidemiology (156) 156
survival (156) 156
tumors (156) 156
lymphoma, b-cell, marginal zone - pathology (155) 155
child (153) 153
lymphoma - epidemiology (153) 153
chronic lymphocytic-leukemia (147) 147
malignant-lymphoma (142) 142
malt lymphoma (142) 142
non-hodgkin-lymphoma (141) 141
immunohistochemistry (135) 135
infection (133) 133
united-states (131) 131
article (125) 125
medical research (124) 124
patients (124) 124
marginal zone lymphoma (122) 122
t cells (122) 122
helicobacter pylori (117) 117
gastroenterology & hepatology (116) 116
therapy (116) 116
non-hodgkin's lymphoma (115) 115
survival rate (114) 114
lymphoma, non-hodgkin - pathology (113) 113
medicine (113) 113
hepatitis c virus (112) 112
lymphocytes b (111) 111
antineoplastic combined chemotherapy protocols - therapeutic use (110) 110
lymphoma - pathology (107) 107
survival analysis (106) 106
development and progression (105) 105
genetic aspects (105) 105
radiotherapy (105) 105
lymphoma, b-cell, marginal zone - diagnosis (101) 101
review (100) 100
immunology (98) 98
lymphoma, b-cell - pathology (97) 97
lymphoproliferative disorders (97) 97
neoplasms (97) 97
expression (96) 96
t-cell lymphoma (96) 96
follow-up studies (95) 95
child, preschool (93) 93
epstein-barr-virus (93) 93
combined modality therapy (92) 92
lymphoma, b-cell, marginal zone - therapy (92) 92
biopsy (91) 91
medicine, experimental (90) 90
disease-free survival (89) 89
lymphocytes (89) 89
animals (87) 87
association (86) 86
lymphoma, b-cell - epidemiology (86) 86
surgery (86) 86
diagnosis, differential (85) 85
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (31) 31
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Online Resources - Online (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2245) 2245
French (17) 17
German (12) 12
Spanish (10) 10
Korean (5) 5
Russian (4) 4
Japanese (3) 3
Arabic (2) 2
Chinese (2) 2
Polish (2) 2
Bulgarian (1) 1
Finnish (1) 1
Italian (1) 1
Latvian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Survival of patients with marginal zone lymphoma: Analysis of the Surveillance, Epidemiology, and End Results database
by Olszewski, Adam J and Castillo, Jorge J
Cancer, ISSN 0008-543X, 02/2013, Volume 119, Issue 3, pp. 629 - 638
BACKGROUND. Prognostic factors and outcomes in patients with marginal zone lymphoma (MZL) have been studied in small cohort studies, which may not reflect the... 
lymphoma, Surveillance | marginal zone B-cell lymphoma | program, epidemiology | Epidemiology | mucosa-associated lymphoid tissue (MALT) | End Results (SEER) | FUTURE-DIRECTIONS | MULTICENTER | PROGNOSTIC-FACTORS | lymphoma | TISSUE LYMPHOMA | program | DISEASE DISSEMINATION | MALT LYMPHOMA | FEATURES | B-CELL LYMPHOMA | THERAPY | Surveillance | ONCOLOGY | RITUXIMAB | Data Interpretation, Statistical | Humans | Middle Aged | Databases, Factual - statistics & numerical data | Lymphoma, B-Cell, Marginal Zone - epidemiology | Male | Lymphoma, B-Cell, Marginal Zone - mortality | Splenic Neoplasms - mortality | Young Adult | Lymphoma, B-Cell, Marginal Zone - ethnology | Splenic Neoplasms - epidemiology | Splenic Neoplasms - pathology | Survival Analysis | Aged, 80 and over | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Aged | SEER Program - statistics & numerical data | Neoplasm Staging | Continental Population Groups - statistics & numerical data | Causes of | Care and treatment | Lymphomas | Prognosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
by Zucca, E and Copie-Bergman, C and Ricardi, U and Thieblemont, C and Raderer, M and Ladetto, M and ESMO Guidelines Working Grp and ESMO Guidelines Working Group and on behalf of the ESMO Guidelines Working Group
Annals of Oncology, ISSN 0923-7534, 2013, Volume 24, Issue 6, pp. vi144 - vi148
SYSTEM | B-CELL LYMPHOMA | MULTICENTER | THERAPY | ONCOLOGY | HELICOBACTER-PYLORI ERADICATION | RITUXIMAB | DISEASE | TISSUE LYMPHOMA | EXPERIENCE | Stomach Neoplasms - diagnosis | Follow-Up Studies | Risk Assessment | Humans | Helicobacter pylori - pathogenicity | Lymphoma, B-Cell, Marginal Zone - epidemiology | Stomach Neoplasms - therapy | Europe - epidemiology | Lymphoma, B-Cell, Marginal Zone - therapy | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Antineoplastic Agents - therapeutic use | Lymphoma, Non-Hodgkin - epidemiology | Anti-Bacterial Agents - therapeutic use | Lymphoid Tissue - pathology | Lymphoma, B-Cell, Marginal Zone - diagnosis | Lymphoma, Non-Hodgkin - therapy | Helicobacter Infections - drug therapy | Stomach Neoplasms - epidemiology | Neoplasm Staging | Lymphoma, Non-Hodgkin - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Splenic marginal zone lymphoma: from genetics to management
by Arcaini, Luca and Rossi, Davide and Paulli, Marco
Blood, ISSN 0006-4971, 04/2016, Volume 127, Issue 17, pp. 2072 - 2081
Splenic marginal zone lymphoma (SMZL) is a rare B-cell malignancy involving the spleen, bone marrow, and frequently the blood. SMZL lymphomagenesis involves... 
FONDAZIONE ITALIANA LINFOMI | RITUXIMAB MONOTHERAPY | 1ST-LINE TREATMENT | B-CELL LYMPHOMA | HEPATITIS-C VIRUS | SIGNIFICANT EFFICACY | NON-HODGKIN-LYMPHOMA | VILLOUS LYMPHOCYTES | KRUPPEL-LIKE FACTOR-2 | HEMATOLOGY | LAPAROSCOPIC SPLENECTOMY | Prognosis | Humans | Receptor, Notch2 - genetics | Hepatitis C, Chronic - complications | Autoimmune Diseases - etiology | Splenectomy | Cell Transformation, Neoplastic - genetics | Paraneoplastic Syndromes - immunology | Neoplasm Proteins - genetics | Splenic Neoplasms - drug therapy | Diagnosis, Differential | Antiviral Agents - therapeutic use | Splenic Neoplasms - genetics | Lymphoma, B-Cell, Marginal Zone - epidemiology | Combined Modality Therapy | Splenic Neoplasms - diagnosis | Hepatitis C, Chronic - drug therapy | Paraneoplastic Syndromes - etiology | Lymphoma, B-Cell, Marginal Zone - genetics | Lymphoma, B-Cell, Marginal Zone - diagnosis | Splenic Neoplasms - epidemiology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Watchful Waiting | Disease Management | Mutation | Kruppel-Like Transcription Factors - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Optimizing therapy for nodal marginal zone lymphoma
by Thieblemont, Catherine and Molina, Thierry and Davi, Frédéric
Blood, ISSN 0006-4971, 04/2016, Volume 127, Issue 17, pp. 2064 - 2071
Nodal marginal zone lymphoma (NMZL) is a rare form of indolent small B-cell lymphoma which has only been clearly identified in the last 2 decades and which to... 
L265P SOMATIC MUTATION | B-CELL LYMPHOMA | CLINICAL PRESENTATION | INDOLENT LYMPHOMA | NON-HODGKINS-LYMPHOMA | TISSUE MALT LYMPHOMA | PHASE-II | RANDOMIZED-TRIAL | FOLLICULAR LYMPHOMA | HEMATOLOGY | NONFOLLICULAR LYMPHOMAS | Lymph Nodes - pathology | Prognosis | Humans | Transcriptome | Lymphoma, B-Cell, Marginal Zone - therapy | Neoplasm Proteins - antagonists & inhibitors | Hepatitis C, Chronic - complications | Molecular Targeted Therapy | Immunotherapy | Adult | Lymphoma, B-Cell, Marginal Zone - pathology | Neoplasm Proteins - genetics | Genetic Association Studies | Antiviral Agents - therapeutic use | Lymphoma, B-Cell, Marginal Zone - epidemiology | Treatment Outcome | Combined Modality Therapy | Hepatitis C, Chronic - drug therapy | Radiotherapy | Disease Progression | Lymphoma, B-Cell, Marginal Zone - genetics | Genes, Immunoglobulin | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Disease Management
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome
by Nocturne, G and Virone, A and Ng, Wan‐Fai and Le Guern, V and Hachulla, E and Cornec, D and Daien, C and Vittecoq, O and Bienvenu, B and Marcelli, C and Wendling, D and Amoura, Z and Dhote, R and Lavigne, C and Fior, R and Gottenberg, J. E and Seror, R and Mariette, X
Arthritis & Rheumatology, ISSN 2326-5191, 04/2016, Volume 68, Issue 4, pp. 977 - 985
Objective To define parameters predictive of lymphoma development in patients with primary Sjögren's syndrome (SS). Methods A multicenter case–control survey... 
HYDROXYCHLOROQUINE | TRIAL | PATHOGENESIS | MULTICENTER | MALIGNANT-LYMPHOMA | RITUXIMAB | RISK | OPEN-LABEL | COHORT | CRYOGLOBULINEMIA | RHEUMATOLOGY | Multivariate Analysis | Humans | Middle Aged | Sjogren's Syndrome - immunology | Male | Case-Control Studies | Cryoglobulinemia - epidemiology | Mycosis Fungoides - epidemiology | Sjogren's Syndrome - epidemiology | Adult | Female | Retrospective Studies | Lymphoma - epidemiology | Severity of Illness Index | Salivary Gland Neoplasms - epidemiology | France - epidemiology | Lymphopenia - epidemiology | Lymphoma, B-Cell, Marginal Zone - epidemiology | Hodgkin Disease - epidemiology | Complement C4 - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology | Skin Neoplasms - epidemiology | Lymphoma, B-Cell - epidemiology | Rheumatoid Factor - immunology | Lung Neoplasms - epidemiology | Lymphoma, Large B-Cell, Diffuse - epidemiology | Aged | United Kingdom - epidemiology | Life Sciences | Human health and pathology | Rhumatology and musculoskeletal system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text High Incidence of Gastrointestinal Tract Disorders and Autoimmunity in Primary Cutaneous Marginal Zone B-Cell Lymphomas
by Guitart, Joan and Deonizio, Janyana and Bloom, Tara and Martinez-Escala, Maria Estela and Kuzel, Timothy M and Gerami, Pedram and Kwasny, Mary and Rosen, Steve T
JAMA Dermatology, ISSN 2168-6068, 04/2014, Volume 150, Issue 4, pp. 412 - 418
IMPORTANCE To our knowledge, this is the first comprehensive study addressing comorbidities associated with primary cutaneous marginal zone B-cell lymphomas... 
WHO-EORTC CLASSIFICATION | BORRELIA-BURGDORFERI | HELICOBACTER-PYLORI | IMMUNOCYTOMA | GENES | DERMATOLOGY | Autoimmunity | Gastrointestinal Diseases - epidemiology | Humans | Middle Aged | Male | Skin Neoplasms - blood | Case-Control Studies | Incidence | Young Adult | Helicobacter pylori | Hashimoto Disease - epidemiology | Antibodies, Antinuclear - blood | Sjogren's Syndrome - epidemiology | Aged, 80 and over | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Surveys and Questionnaires | Lymphoma, B-Cell, Marginal Zone - blood | Skin Neoplasms - pathology | Comorbidity | Lupus Erythematosus, Systemic - epidemiology | Helicobacter Infections - epidemiology | Lymphoma, B-Cell, Marginal Zone - epidemiology | Skin Neoplasms - epidemiology | Adolescent | Aged | Neoplasms - epidemiology | Dermatomycoses | Complications and side effects | Gastrointestinal diseases | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Sjögren Syndrome‐associated lymphomas: an update on pathogenesis and management
by Nocturne, Gaetane and Mariette, Xavier
British Journal of Haematology, ISSN 0007-1048, 02/2015, Volume 168, Issue 3, pp. 317 - 327
Summary Primary Sjögren Syndrome (pSS) is an autoimmune disease associated with an increased risk of lymphoma. Lymphomas complicating pSS are mostly low‐grade... 
auto‐immunity | mucosa‐associated lymphoid tissue lymphoma | lymphomagenesis | NF‐kB | Sjögren syndrome | Mucosa-associated lymphoid tissue lymphoma | Lymphomagenesis | Auto-immunity | NF-kB | MALIGNANT-LYMPHOMA | TISSUE LYMPHOMA | PROGNOSTIC VALUE | GERMINAL CENTER FORMATION | B-CELLS | EPITHELIAL-CELLS | CELL-ACTIVATING FACTOR | auto-immunity | C VIRUS-INFECTION | NON-HODGKIN-LYMPHOMA | mucosa-associated lymphoid tissue lymphoma | Sjogren syndrome | HEMATOLOGY | SALIVARY-GLAND LYMPHOMAS | Cell Transformation, Neoplastic - immunology | Humans | Risk Factors | Lymphoma, B-Cell, Marginal Zone - epidemiology | Sjogren's Syndrome - epidemiology | Lymphoma, B-Cell, Marginal Zone - etiology | Lymphoma, B-Cell, Marginal Zone - therapy | Sjogren's Syndrome - immunology | Hepatitis C, Chronic - complications | Sjogren's Syndrome - complications | Lymphomas | B cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review
by Michiel van den Brand and J. Han J.M. van Krieken
Haematologica, ISSN 0390-6078, 07/2013, Volume 98, Issue 7, pp. 1003 - 1013
The diagnosis of nodal marginal zone lymphoma is one of the remaining problem areas in hematopathology. Because no established positive markers exist for this... 
MUTATION ANALYSIS | NON-HODGKIN LYMPHOMAS | PLASMACYTIC DIFFERENTIATION | B-CELL LYMPHOMA | HEPATITIS-C VIRUS | SOMATIC HYPERMUTATION | CLINICAL PRESENTATION | BONE-MARROW | COMPARATIVE GENOMIC HYBRIDIZATION | CHROMOSOMAL-ABERRATION | HEMATOLOGY | Lymphoma, B-Cell, Marginal Zone - therapy | Animals | Lymphoma, B-Cell, Marginal Zone - diagnosis | Humans | Lymphoma, B-Cell, Marginal Zone - epidemiology | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Medical History, Lifestyle, Family History, and Occupational Risk Factors for Marginal Zone Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project
by Bracci, Paige M and Benavente, Yolanda and Turner, Jennifer J and Paltiel, Ora and Slager, Susan L and Vajdic, Claire M and Norman, Aaron D and Cerhan, James R and Chiu, Brian C. H and Becker, Nikolaus and Cocco, Pierluigi and Dogan, Ahmet and Nieters, Alexandra and Holly, Elizabeth A and Kane, Eleanor V and Smedby, Karin E and Maynadié, Marc and Spinelli, John J and Roman, Eve and Glimelius, Bengt and Wang, Sophia S and Sampson, Joshua N and Morton, Lindsay M and de Sanjosé, Silvia
Journal of the National Cancer Institute Monographs, ISSN 1052-6773, 8/2014, Volume 2014, Issue 48, pp. 52 - 65
Background Marginal zone lymphoma (MZL), comprised of nodal, extranodal, and splenic subtypes, accounts for 5%–10% of non-Hodgkin lymphoma cases. A detailed... 
Life Style | Comorbidity | Humans | Middle Aged | Occupational Exposure | Risk Factors | Lymphoma, B-Cell, Marginal Zone - epidemiology | Australia - ethnology | Europe - epidemiology | Male | Australia - epidemiology | Case-Control Studies | Europe - ethnology | Young Adult | North America - ethnology | Lymphoma, B-Cell, Marginal Zone - diagnosis | Aged, 80 and over | Lymphoma, B-Cell, Marginal Zone - etiology | Adult | Female | Aged | North America - epidemiology | Odds Ratio
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Conjunctival Lymphoma—An International Multicenter Retrospective Study
by Kirkegaard, Marina M and Rasmussen, Peter K and Coupland, Sarah E and Esmaeli, Bita and Finger, Paul T and Graue, Gerardo F and Grossniklaus, Hans E and Honavar, Santosh G and Khong, Jwu J and McKelvie, Penny A and Mulay, Kaustubh and Prause, Jan U and Ralfkiaer, Elisabeth and Sjö, Lene D and Toft, Peter B and Vemuganti, Geeta K and Thuro, Bradley A and Curtin, Jeremy and Heegaard, Steffen
JAMA Ophthalmology, ISSN 2168-6165, 04/2016, Volume 134, Issue 4, pp. 406 - 414
IMPORTANCE: To date, the clinical features of the various subtypes of conjunctival lymphoma (CL) have not been previously evaluated in a large cohort.... 
CLINICAL-PRACTICE GUIDELINES | WALDEYERS RING | MANTLE CELL LYMPHOMA | LYMPHOPROLIFERATIVE DISEASE | OCULAR ADNEXA | OPHTHALMOLOGY | NON-HODGKIN-LYMPHOMA | FOLLOW-UP | FOLLICULAR LYMPHOMA | MARGINAL ZONE LYMPHOMA | FEATURES | Immunohistochemistry | Lymphoma, Follicular - therapy | Prognosis | Humans | Middle Aged | Lymphoma, B-Cell, Marginal Zone - therapy | Male | Burkitt Lymphoma - epidemiology | Incidence | Burkitt Lymphoma - pathology | Lymphoma, Follicular - epidemiology | Lymphoma, Large B-Cell, Diffuse - therapy | Lymphoma - therapy | Neoplasm Invasiveness - pathology | Female | Lymphoma - pathology | Lymphoma, B-Cell, Marginal Zone - pathology | Retrospective Studies | Databases, Factual | Burkitt Lymphoma - therapy | Lymphoma - epidemiology | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Lymphoma, B-Cell, Marginal Zone - epidemiology | Conjunctival Neoplasms - therapy | Conjunctival Neoplasms - pathology | Disease-Free Survival | Conjunctival Neoplasms - epidemiology | Internationality | Lymphoma, Large B-Cell, Diffuse - epidemiology | Survival Analysis | Aged | Biopsy, Needle | Neoplasm Staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site
by Khalil, Mohammad O and Morton, Lindsay M and Devesa, Susan S and Check, David P and Curtis, Rochelle E and Weisenburger, Dennis D and Dores, Graça M
British Journal of Haematology, ISSN 0007-1048, 04/2014, Volume 165, Issue 1, pp. 67 - 77
Summary The aetiology of marginal zone lymphoma (MZL) is purported to differ by anatomic site. While this is supported by clinical series of single MZL sites,... 
anatomic site | incidence | population‐based study | marginal zone lymphoma | joinpoint analysis | Population-based study | Joinpoint analysis | Anatomic site | Marginal zone lymphoma | Incidence | population-based study | B-CELL LYMPHOMAS | CANCER INCIDENCE | VARIABLE FREQUENCIES | SJOGRENS-SYNDROME | TISSUE LYMPHOMA | MALT LYMPHOMAS | PRIMARY GASTRIC LYMPHOMA | RISK-FACTOR | HELICOBACTER-PYLORI INFECTION | NON-HODGKIN-LYMPHOMA | HEMATOLOGY | United States - epidemiology | SEER Program | Age Factors | History, 21st Century | United States - ethnology | Lymphoma, B-Cell, Marginal Zone - history | Humans | Middle Aged | Lymphoma, B-Cell, Marginal Zone - epidemiology | Male | Young Adult | Adolescent | Sex Factors | Aged, 80 and over | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Aged | Child | Lymphomas
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?
by Kiesewetter, Barbara and Lukas, Julius and Dolak, Werner and Simonitsch-Klupp, Ingrid and Mayerhoefer, Marius E and Raderer, Markus
Oncology, ISSN 0030-2414, 11/2016, Volume 91, Issue 5, pp. 243 - 250
Objectives: Gender-related aspects have been investigated in a variety of tumor entities including results on sex-specific differences in non-Hodgkin lymphoma.... 
Clinical Study | Extranodal lymphoma | Gender medicine | Mucosa-associated lymphoid tissue lymphoma | Indolent lymphoma | Gender aspects | GASTRIC MALT LYMPHOMA | RISK | ONCOLOGY | RITUXIMAB | DISEASE | REPRODUCTIVE FACTORS | NON-HODGKIN-LYMPHOMA | HELICOBACTER | SINGLE-CENTER ANALYSIS | Follow-Up Studies | Humans | Middle Aged | Helicobacter Infections - epidemiology | Lymphoma, B-Cell, Marginal Zone - epidemiology | Male | Survival Rate | Parotid Neoplasms - epidemiology | Lymphoma, B-Cell, Marginal Zone - mortality | Disease-Free Survival | beta 2-Microglobulin - blood | Helicobacter pylori | Helicobacter Infections - drug therapy | Lymphoma, B-Cell, Marginal Zone - drug therapy | Sex Factors | Female | Stomach Neoplasms - epidemiology | Aged | Retrospective Studies | Breast Neoplasms - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights